| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer
1 company
Welgus Howard G. is a Director at Arcutis Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $989K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Director | Sale+OE | 4,731 | $24.58 | $116,280.94 | -5.9% | - | - | |
| Jan 2, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Director | Sell | 10,000 | $28.96 | $289,606.00 | -12.5% | -18.5% | - | |
| Dec 1, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Director | Sell | 10,000 | $30.21 | $302,133.00 | -11.1% | -18.5% | - | |
| Nov 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Director | Sell | 10,000 | $25.27 | $252,669.00 | -10.0% | +3.3% | - | |
| Oct 1, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Director | Sale+OE | 10,000 | $18.92 | $189,227.00 | -4.8% | +42.1% | - | |
| Sep 2, 2025 | ARQT Arcutis Biotherapeutics, Inc. | - | Sale+OE | 10,000 | $15.64 | $156,383.00 | -9.1% | +98.2% | - | |
| Aug 1, 2025 | ARQT Arcutis Biotherapeutics, Inc. | - | Sale+OE | 10,000 | $14.30 | $142,982.00 | -4.8% | +74.4% | - | |
| Jul 1, 2025 | ARQT Arcutis Biotherapeutics, Inc. | - | Sell | 9,208 | $13.84 | $127,430.43 | -8.4% | +35.4% | - | |
| Jun 18, 2025 | ARQT Arcutis Biotherapeutics, Inc. | - | Sell | 10,139 | $13.37 | $135,573.64 | -8.5% | +24.1% | +91.7% | |
| May 1, 2025 | ARQT Arcutis Biotherapeutics, Inc. | - | Sell | 10,000 | $14.64 | $146,357.00 | -8.2% | -0.5% | +59.4% |